Source:http://linkedlifedata.com/resource/pubmed/id/12153178
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0033684,
umls-concept:C0035696,
umls-concept:C0210994,
umls-concept:C0242640,
umls-concept:C0278519,
umls-concept:C0381666,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0872262,
umls-concept:C0879392,
umls-concept:C0919458,
umls-concept:C1515568,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1704873
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-8-2
|
pubmed:abstractText |
In this study, 86 children (58 initial ALL and 28 children with relapsed disease) were investigated for lung resistance protein (LRP) and multidrug resistance related protein (MRPI)-mRNA expression by semiquantitative RT-PCR. The majority of investigated cases demonstrated variable LRP and MRP1 mRNA expression, when normalized for beta-microglobulin expression. LRP and MRPI mRNA expression may be coordinately regulated, as expression of both transcripts was found to be significantly correlated (p = 0.0001). No differences of LRP and MRP expression were observed between initial and relapsed stage patients (LRP: p = 0.89 and for MRP: p = 0.09). The prognostic value of both resistance mechanisms was subjected to Kaplan-Meier analysis for event-free survival. For this analysis the patients were divided into groups with high or low LRP or MRPI mRNA expression by utilizing the median value as the cut-off point. Overexpression of both resistance mechanisms had no prognostic significance in our retrospective study (log-rank test for LRP: p = 0.12 and for MRPI: p = 0.95), however, patients who showed high LRP expression exhibited a lower tendency of remaining in continuous first remission.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Vault Ribonucleoprotein Particles,
http://linkedlifedata.com/resource/pubmed/chemical/major vault protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
875-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12153178-Adolescent,
pubmed-meshheading:12153178-Adult,
pubmed-meshheading:12153178-Child,
pubmed-meshheading:12153178-Child, Preschool,
pubmed-meshheading:12153178-Female,
pubmed-meshheading:12153178-Gene Expression,
pubmed-meshheading:12153178-Humans,
pubmed-meshheading:12153178-Infant,
pubmed-meshheading:12153178-Male,
pubmed-meshheading:12153178-Neoplasm Proteins,
pubmed-meshheading:12153178-P-Glycoprotein,
pubmed-meshheading:12153178-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:12153178-RNA, Messenger,
pubmed-meshheading:12153178-Retrospective Studies,
pubmed-meshheading:12153178-Vault Ribonucleoprotein Particles
|
pubmed:year |
2002
|
pubmed:articleTitle |
Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia.
|
pubmed:affiliation |
Department of Pediatrics, University of Jena, Germany. axel.sauerbrey@med.uni-jena.de
|
pubmed:publicationType |
Journal Article
|